S&P 500   3,286.68 (+0.32%)
DOW   28,830.38 (+0.37%)
QQQ   222.17 (+0.33%)
FB   222.70 (+2.25%)
MSFT   167.34 (+1.14%)
GOOGL   1,457.24 (+0.46%)
AMZN   1,864.59 (+0.61%)
CGC   24.10 (+0.75%)
NVDA   244.85 (-1.26%)
BABA   210.34 (+0.05%)
MU   55.86 (-1.08%)
GE   12.90 (+9.97%)
TSLA   574.18 (+1.28%)
AMD   46.88 (-7.24%)
T   37.30 (-3.32%)
ACB   1.97 (+0.00%)
F   8.88 (-1.11%)
NFLX   344.23 (-1.23%)
PRI   121.25 (+0.51%)
BAC   33.35 (+0.33%)
GILD   64.45 (+0.12%)
S&P 500   3,286.68 (+0.32%)
DOW   28,830.38 (+0.37%)
QQQ   222.17 (+0.33%)
FB   222.70 (+2.25%)
MSFT   167.34 (+1.14%)
GOOGL   1,457.24 (+0.46%)
AMZN   1,864.59 (+0.61%)
CGC   24.10 (+0.75%)
NVDA   244.85 (-1.26%)
BABA   210.34 (+0.05%)
MU   55.86 (-1.08%)
GE   12.90 (+9.97%)
TSLA   574.18 (+1.28%)
AMD   46.88 (-7.24%)
T   37.30 (-3.32%)
ACB   1.97 (+0.00%)
F   8.88 (-1.11%)
NFLX   344.23 (-1.23%)
PRI   121.25 (+0.51%)
BAC   33.35 (+0.33%)
GILD   64.45 (+0.12%)
S&P 500   3,286.68 (+0.32%)
DOW   28,830.38 (+0.37%)
QQQ   222.17 (+0.33%)
FB   222.70 (+2.25%)
MSFT   167.34 (+1.14%)
GOOGL   1,457.24 (+0.46%)
AMZN   1,864.59 (+0.61%)
CGC   24.10 (+0.75%)
NVDA   244.85 (-1.26%)
BABA   210.34 (+0.05%)
MU   55.86 (-1.08%)
GE   12.90 (+9.97%)
TSLA   574.18 (+1.28%)
AMD   46.88 (-7.24%)
T   37.30 (-3.32%)
ACB   1.97 (+0.00%)
F   8.88 (-1.11%)
NFLX   344.23 (-1.23%)
PRI   121.25 (+0.51%)
BAC   33.35 (+0.33%)
GILD   64.45 (+0.12%)
S&P 500   3,286.68 (+0.32%)
DOW   28,830.38 (+0.37%)
QQQ   222.17 (+0.33%)
FB   222.70 (+2.25%)
MSFT   167.34 (+1.14%)
GOOGL   1,457.24 (+0.46%)
AMZN   1,864.59 (+0.61%)
CGC   24.10 (+0.75%)
NVDA   244.85 (-1.26%)
BABA   210.34 (+0.05%)
MU   55.86 (-1.08%)
GE   12.90 (+9.97%)
TSLA   574.18 (+1.28%)
AMD   46.88 (-7.24%)
T   37.30 (-3.32%)
ACB   1.97 (+0.00%)
F   8.88 (-1.11%)
NFLX   344.23 (-1.23%)
PRI   121.25 (+0.51%)
BAC   33.35 (+0.33%)
GILD   64.45 (+0.12%)
Log in

NASDAQ:ESRX - Express Scripts Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$92.33
0.00 (0.00 %)
(As of 01/29/2020 12:11 PM ET)
Today's Range
$92.33
Now: $92.33
$92.33
50-Day Range
$92.33
MA: $92.33
$92.33
52-Week Range
$66.93
Now: $92.33
$101.73
VolumeN/A
Average Volume6.64 million shs
Market Capitalization$52.06 billion
P/E Ratio13.00
Dividend YieldN/A
Beta0.88
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNASDAQ:ESRX
CUSIP30219G10
Phone314-996-0900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$100.06 billion
Cash Flow$10.49 per share
Book Value$32.00 per share

Profitability

Net Income$4.52 billion

Miscellaneous

EmployeesN/A
Market Cap$52.06 billion
Next Earnings DateN/A
OptionableOptionable

Receive ESRX News and Ratings via Email

Sign-up to receive the latest news and ratings for ESRX and its competitors with MarketBeat's FREE daily newsletter.


Express Scripts (NASDAQ:ESRX) Frequently Asked Questions

What is Express Scripts' stock symbol?

Express Scripts trades on the NASDAQ under the ticker symbol "ESRX."

How were Express Scripts' earnings last quarter?

Express Scripts Holding Co (NASDAQ:ESRX) released its quarterly earnings results on Wednesday, October, 31st. The company reported $2.43 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $2.42 by $0.01. The firm had revenue of $25.56 billion for the quarter, compared to analysts' expectations of $25.11 billion. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The business's revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the firm earned $2.51 EPS. View Express Scripts' Earnings History.

Has Express Scripts been receiving favorable news coverage?

News stories about ESRX stock have trended very negative on Wednesday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Express Scripts earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the next few days. View News Stories for Express Scripts.

Who are some of Express Scripts' key competitors?

What other stocks do shareholders of Express Scripts own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Express Scripts investors own include Gilead Sciences (GILD), General Electric (GE), Intel (INTC), Cisco Systems (CSCO), Bank of America (BAC), Walt Disney (DIS), Boeing (BA), CVS Health (CVS), Starbucks (SBUX) and Celgene (CELG).

Who are Express Scripts' key executives?

Express Scripts' management team includes the folowing people:
  • Mr. Timothy C. Wentworth, CEO, Pres & Director (Age 58)
  • Mr. James M. Havel, Exec. VP & CFO (Age 63)
  • Mr. David A. Queller, Sr. VP of Sales & Account Management (Age 49)
  • Ms. Christine Houston, Exec. VP of Strategic Integrations (Age 55)
  • Mr. Everett Neville, Exec. VP of Strategy, Supply Chain & Specialty (Age 53)

What is Express Scripts' stock price today?

One share of ESRX stock can currently be purchased for approximately $92.33.

How big of a company is Express Scripts?

Express Scripts has a market capitalization of $52.06 billion and generates $100.06 billion in revenue each year. The company earns $4.52 billion in net income (profit) each year or $7.10 on an earnings per share basis. View Additional Information About Express Scripts.

What is Express Scripts' official website?

The official website for Express Scripts is http://www.express-scripts.com/.

How can I contact Express Scripts?

Express Scripts' mailing address is ONE EXPRESS WAY, SAINT LOUIS MO, 63121. The company can be reached via phone at 314-996-0900 or via email at [email protected]


MarketBeat Community Rating for Express Scripts (NASDAQ ESRX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  1,027 (Vote Outperform)
Underperform Votes:  728 (Vote Underperform)
Total Votes:  1,755
MarketBeat's community ratings are surveys of what our community members think about Express Scripts and other stocks. Vote "Outperform" if you believe ESRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ESRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel